LipoScience Company Profile (NASDAQ:LPDX)

About LipoScience (NASDAQ:LPDX)

LipoScience logoLipoScience, Inc. is a vitro diagnostic company. The Company's diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company's Vantera system is the Company's automated clinical analyzer. As of January 25, 2013, over eight million NMR LipoProfile tests were ordered. The Vantera system is its automated clinical analyzer. In August 2012, the Company received Food and Drug Administration (FDA) clearance to market the Vantera system commercially to laboratories.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:LPDX
  • CUSIP: 53630M10
  • Web: N/A
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: -6.24
  • P/E Growth:
  • Dividend Yield: 1.0%

Frequently Asked Questions for LipoScience (NASDAQ:LPDX)

What is LipoScience's stock symbol?

LipoScience trades on the NASDAQ under the ticker symbol "LPDX."

How were LipoScience's earnings last quarter?

LipoScience Inc (NASDAQ:LPDX) issued its quarterly earnings data on Wednesday, November, 12th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.02. The firm had revenue of $8.56 million for the quarter, compared to analyst estimates of $8.80 million. During the same quarter last year, the firm earned ($0.31) earnings per share. View LipoScience's Earnings History.

Who are some of LipoScience's key competitors?

How do I buy LipoScience stock?

Shares of LipoScience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LipoScience's stock price today?

One share of LipoScience stock can currently be purchased for approximately $5.24.

MarketBeat Community Rating for LipoScience (NASDAQ LPDX)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  70
MarketBeat's community ratings are surveys of what our community members think about LipoScience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for LipoScience (NASDAQ:LPDX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for LipoScience (NASDAQ:LPDX)
No equities research coverage for this company has been tracked by


Earnings History for LipoScience (NASDAQ:LPDX)
Earnings by Quarter for LipoScience (NASDAQ:LPDX)
Earnings History by Quarter for LipoScience (NASDAQ LPDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/12/2014Q3 14($0.26)($0.28)$8.80 million$8.56 millionViewN/AView Earnings Details
8/12/2014Q2 2014($0.24)($0.27)$8.90 million$9.05 millionViewN/AView Earnings Details
5/12/2014Q1 14($0.19)($0.13)$12.25 million$12.01 millionViewN/AView Earnings Details
3/10/2014Q413($0.24)($0.17)$12.71 million$12.72 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LipoScience (NASDAQ:LPDX)
Current Year EPS Consensus Estimate: $-0.93 EPS
Next Year EPS Consensus Estimate: $-0.84 EPS


Dividend History for LipoScience (NASDAQ:LPDX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for LipoScience (NASDAQ:LPDX)
Insider Trades by Quarter for LipoScience (NASDAQ:LPDX)
Insider Trades by Quarter for LipoScience (NASDAQ:LPDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2013Daniel LevangieDirectorBuy10,000$4.17$41,700.00View SEC Filing  
12/4/2013E. Duffy McdonaldVPSell12,731$4.07$51,815.17View SEC Filing  
11/25/2013James HurleyDirectorBuy5,100$3.91$19,941.00View SEC Filing  
11/18/2013Robert Greczyn, Jr.CEOBuy10,000$4.15$41,500.00View SEC Filing  
1/30/2013Buzz BensonDirectorBuy50,000$9.00$450,000.00View SEC Filing  
1/30/2013Three Arch Capital LpMajor ShareholderBuy215,000$9.00$1,935,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LipoScience (NASDAQ:LPDX)
Latest Headlines for LipoScience (NASDAQ:LPDX)
DateHeadline logoMiraculins: Pioneering a New Approach to Diabetes Screening - January 27 at 8:00 AM logoUS STOCKS-Cantor turns bearish on U.S. equities - September 25 at 10:27 AM



LipoScience (LPDX) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by Staff